Human myocardial tissue TNFα expression following acute global ischemia in vivo

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 9, 1998, Pages 1683-1689

  Meldrum, Daniel R ^a   Meng, Xianzhong ^a   Dinarello, Charles A ^a   Ayala, Alfred ^b   Cain, Brian S ^a   Shames, Brian D ^a   Ao, Lihua ^a   Banerjee, Anirban ^a   Harken, Alden H ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Cardiac operations; Cardiopulmonary bypass; Cytokines; Heart; Immunohistochemistry; Patients

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CARDIOPULMONARY BYPASS; CASE REPORT; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART MUSCLE BIOPSY; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL;

EID: 0032167388     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0776     Document Type: Article

References (47)

1. 3, in plasma after experimental myocardial infarction. J Mol Cell Cardiol 29: 1-9.
2. AYALA A, PERRIN MM, MELDRUM DR, ERTEL W, CHAUDRY IH, 1990. Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine 2: 170-174.
3. AYALA A, PERRIN MM, WANG P, ERTEL W, CHAUDRY IH, 1991a. Hemorrhage induces enhanced Kupffer cell cytoxicity while decreasing peritoneal or splenic macrophage capacity. J Immunol 147: 4147-4154.
4. AYALA A, WANG P, BA ZD, PERRIN MM, ERTEL W, CHAUDRY IH, 1991b. Differential alterations in plasma IL-6 and TNF levels after trauma and hemorrhage. Am J Physiol 260: R167-R171.
5. AYALA A, HERNDON CD, LEHMAN DL, AYALA CA, CHAUDRY IH, 1996. Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators. Blood 87: 4261-4275.
6. BARNES PJ, KARVIN M, 1997. Nuclear factor kappa B-A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-1071.
7. BOGOYEVITCH MA, GILLESPIE-BROWN J, KETTERMAN AJ, FULLER SJ, BEN-LEVY R, ASHWORTH A, MARSHALL CJ, SUGDEN PH, 1996. Stimulation of the stress-activated mitogen activated protein kinase subfamilies in perfused heart: p38/RK mitogen activated protein kinases and c-Jun N-Terminal kinases are activated by ischemia/reperfusion. Circ Res 79: 162-173.
8. BRADY AJB, POOLE-WILSON PA, HARDING SE, WARREN JB, 1992. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 263: H1963-H1966.
9. BROWN JM, TERADA LS, GROSSO MA, WHITMAN GJ, VELASCO SE, PATT A, HARKEN AH, REPINE JE, 1988. Xanthine oxidase produces hydrogen peroxide which contributes Mengto reperfusion injury of ischemic isolated rat hearts. J Clin Invest 81: 1297-1301.
10. CLEVELAND JC, MELDRUM DR, CAIN BS, BANERJEE A, HARKEN AH, 1997. Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Circulation 96: 29-32.
11. DINARELLO CA, 1996. Biologic basis for interleukin 1 in disease. Blood 87: 2095-2147.
12. DINARELLO CA, GELFAND JA, WOLFF SM, 1993. Anticytokine strategies in the treatment of the sytemic inflammatory response syndrome. JAMA 269: 1829-1835.
13. FINKEL TH, PABST MJ, SUZUKI H, GUTHRIE LA, FOREHAND JR, PHILLIPS WA, JOHNSTON RB, 1987. Priming of neutrophils and macrophage for the enhanced release of superoxide anion by the calcium ionophore ionomycin: Implications for regulation of the respiratory burst. J Biol Chem 262: 12589-12596.
14. FINKEL MS, ODDIS CV, JACOB TD, WATKINS SC, HATTLER BG, SIMMONS RL, 1992. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387-389.
15. GIROIR BP, JOHNSON JH, BROWN T, ALLEN GL, BEUTLER B, 1992. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest 90: 693-698.
16. GUREVITCH J, FROLKIS I, YUHAS Y, PAZ Y, MATSA M, MOHR R, YAKIREVICH V, 1996. Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion. J Am Coll Cardiol 28: 247-252.
17. ISHIYAMA S, HIROE M, NISHIKAWA T, ABE S, SHIMOJO T, ITO H, et al., 1997. Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis. Circulation 95: 489-496.
18. KAJSTURA J, CHENG W, REISS K, CLARK WA, SONNENBLICK EH, KRAJEWSKI S, REED JC, OLIVETTI G, ANVERSA P, 1996. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 74: 86-107.
19. KAPADIA S, LEE J, TORRE-AMIONE G, BIRDSALL HH, MA TS, MANN DL, 1995. Tumor necrosis factor-α gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 96: 1042-1052.
20. KELLY RA, SMITH TW, 1997. Cytokines and cardiac contractile function. Circulation 95: 778-781.
21. KITAKAZE M, NODE K, KOMAMURA K, MINAMINO T, INOUE M, HORI M, KAMADA T, 1995. Evidence for nitric oxide generation in the cardiomyocytes: its augmentation by hypoxia. J Mol Cell Cardiol 27: 2149-2154.
22. KROWN KA, PAGE MT, NGUYEN C, ZECHNER D, GUTIERREZ V, COMSTOCK KL, GLEMBOTSKI CG, QUINTANA PJE, SABBADINI RA, 1996. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes: involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 98: 2854-2865.
23. KUMAR A, THOTA V, DEE L, OLSON J, URETZ E, PARRILLO JE, 1996. Tumor necrosis factor-alpha and interleukin 1-beta are responsible for the in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 183: 949-958.
24. LAST-BARNEY K, HOMON CA, FAANES RB, MERLUZZI VJ, 1988. Synergistic and overlapping activities of tumor necrosis factor-α and IL-1. J Immunol 141: 527-530.
25. LATINI R, BIANCHI M, CORREALE E, DINARELLO CA, FANTUZZI G, FRESCO C, MAGGOINI AP, MENGOZZI M, ROMANO S, SHAPIRO L, 1994. Cytokines in acute myocardial infarction: selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin 1 receptor antagonist. J Cardiovasc Pharmacol 23: 1-6.
26. LEVINE B, KALMAN J, MAYER L, FILLIT H, PACKER M, 1990. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323: 236-241.
27. MELDRUM DR, 1998. Tumor necrosis factor in the heart (Review). Am J Physiol 274: R577-R595.
28. MELDRUM DR, AYALA A, WANG P, ERTEL W, CHAUDRY IH, 1991. Association between decreased splenic ATP levels and immunodepression. Am J Physiol 261: R351-R357.
29. MELDRUM DR, AYALA A, CHAUDRY IH, 1993. Mechanism of diltiazem's immunomodulatory effects following hemorrhage and resuscitation. Am J Physiol 265: C412-C421.
30. MELDRUM DR, CLEVELAND JC, SHERIDAN BC, ROWLAND RT, BANERJEE A, HARKEN AH, 1996. Cardiac surgical implications of calcium dyshomeostasis in the heart. Ann Thorac Surg 61: 1273-1280.
31. MELDRUM DR, CAIN BS, CLEVELAND JC, MENG X, AYALA A, BANERJEE A, HARKEN AH, 1997a. Adenosine decreases post-ischemic myocardial TNFα production: anti-inflammatory implications for preconditioning and transplantation. Immunology 92: 472-477.
32. 1-adrenoceptor mediated, protein synthesis independent mechanism. Am J Physiol 272: R718-R725.
33. MELDRUM DR, DINARELLO CA, MENG X, SHAPIRO L, HARKEN AH, 1997c. P38 MAP kinase-mediated myocardial TNFα production contributes to post-ischemic cardiac dysfunction. Circulation 96: 1-556.
34. MELDRUM DR, SHENKAR R, SHERIDAN BC, CAIN BS, ABRAHAM E, HARKEN AH, 1997d. Hemorrhage activates myocardial NFκB and increases tumor necrosis factor in the heart. J Mol Cell Cardiol 29: 2849-2854.
35. MELDRUM DR, CLEVELAND JC, CAIN BS, MENG X, HARKEN AH, 1998. Increased myocardial TNFα in a crystalloid-perfused model of cardiac ischemia-reperfusion injury. Ann Thorac Surg 65: 439-443.
36. MENG X, BROWN JM, AO L, FRANKLIN W, BANERJEE A, HARKEN AH, 1996. Heat shock protein 70 contributes to the induced cardiac resistance to bacterial lipopolysaccharide in the rat. Am J Physiol 271: C1316-C1324.
37. MENG X, AO L, BROWN JM, FULLERTON DA, BANERJEE A, HARKEN AH, 1997. Nitric oxide synthase is not involved in cardiac contractile dysfunction in a rat model of endotoxemia without shock. Shock 7: 111-118.
38. NEUMANN FJ, OTT I, GAWAZ M, RICHARDT G, HOLZAPFEL H, JOCHUM M, SCHOMIG A, 1995. Cardiac release of cytokines and inflammatory responses in acute myo-cardial infarction. Circulation 92: 748-755.
39. ORAL H, DORN GW, MANN DL, 1997. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-α in the adult mammalian cardiac myocyte. J Biol Chem 272: 4836-4842.
40. SARASTE A, PULKKI K, KALLAJOKI M, HENRIKSEN K, PARVINEN M, VOIPIO-PULKKI LM, 1997. Apoptosis in human acute myocardial infarction. Circulation 95: 320-323.
41. TORRE-AMIONE G, KAPADIA S, LEE J, BIES RD, LEBOVITZ R, MANN DL, 1995. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 92: 1487-1493.
42. TORRE-AMIONE G, KAPADIA S, BENEDICT C, ORAL H, YOUNG JB, MANN DL, 1996a. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 27: 1201-1206.
43. TORRE-AMIONE G, KAPADIA S, LEE J, DURAND JB, BIES RD, YOUNG JB, MANN DL, 1996b. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation 93: 704-711.
44. WAN S, DESMET JM, BARVAIS L, GOLSTEIN M, VINCENT JL, LECLERC JL, 1996. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 112: 806-811.
45. WANG P, ZWEIER JL, 1996. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart: evidence for peroxynitrite-mediated reperfusion injury. J Biol Chem 271: 29223-29230.
46. YOKOYAMA T, VACA L, ROSSEN RD, DURANTE W, HAZARIKA P, MANN DL, 1993. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian cardiac myocyte. J Clin Invest 92: 2303-2312.
47. YOKOYAMA T, NAKANO M, BEDNARCZYK JL, MCINTYRE BW, ENTMAN M, MANN DL, 1997. Tumor necrosis factor-α provokes a hypertrophic growth response in adult cardiac myocytes. Circulation 95: 1247-1252.